Tolerability, Safety and Effectiveness of Edratide in the Treatment of Lupus
- Study Title
- A Study to Evaluate the Tolerability, Safety and Effectiveness of Edratide in the Treatment of Lupus
- Teva Identifier
- TV-4710/201
- ClinicalTrials.gov Identifier
- NCT00203151
- Study Status
- Terminated
- Trial Condition(s)
- Systemic Lupus Erythematosus
- Interventions
- Drug: edratide
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years to 65 Years
- Trial Duration
- 07/01/2005 - 02/01/2007
- Phase
- Phase 2
